๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy

โœ Scribed by Hachimi-Idrissi, S.; De Schepper, J.; Maurus, R.; Otten, J.

Book ID
122986401
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
296 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tropisetron in the prevention of nausea
Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy
โœ Benoit, Yves ;Hulstaert, Frank ;Vermylen, Christiane ;Sariban, Eric ;Hoyoux, Cla ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 649 KB

## Abstract Tropisetron (Navobanยฎ, Sandoz Pharma Ltd., Basel, Switzerland), a selective antagonist of the serotonin receptor (5โ€HT3) dosed onceโ€daily at 0.2 mg/kg (with a maximum of 5 mg daily), was evaluated in the prevention of chemotherapyโ€induced nausea and vomiting in 131 children with a media

Letter to the editor: Tropisetron in the
Letter to the editor: Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy
โœ Berberoglu, Semha ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 10 KB ๐Ÿ‘ 3 views

Tropisetron in the Prevention of Nausea and Vomiting in 131 Children Receiving Cytotoxic Chemotherapy I have read with interest the report by Benoit et al. [1] were two infants. I agree with the authors that the efficacy and safety data was similar to those reported for older concerning the efficacy